Bausch Health Companies | VRX - Ebit


Bausch Health Companies reported $993M in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
Amgen USD 4.61B 777M Jun/2026
ANI Pharmaceuticals USD 39.84M 1.13M Jun/2026
Aurora Cannabis CAD 7.12M 42.91M Mar/2026
Bausch Health Companies USD 993M 217M Sep/2026
Biogen USD 419.5M 663.3M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Canopy Growth CAD -145.65M 132.99M Mar/2026
Corcept Therapeutics USD 41.3M 90.9M Jun/2026
Danaher USD 1.25B 118M Sep/2026
Drreddys Laboratories INR 3.05B 13.32B Mar/2026
Eli Lilly USD 13.09B 635M Sep/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Novo Nordisk DKK 33.76B 25.86B Jun/2026
Pacira USD 9.96M 5.33M Jun/2026
Perrigo USD 33.6M 50.8M Mar/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 52.52M 22.97M Jun/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026
Vertex Pharmaceuticals USD 1.27B 129.9M Jun/2026
Zoetis USD 1.12B 279M Jun/2026